Effect of everolimus plus reduced-dose tacrolimus in de novo living-donor liver transplantation recipients on recurrence of HCC: 24 months subgroup analysis from the H2307 study

L. -B. Jeng,S. -G. Lee, A. S. Soin,W. -C. Lee,K. -S. Suh,D. J. Joo, S. Uemoto,M. Meier, J. Kochuparampil, C. Sips,S. Kaneko,G. Levy

TRANSPLANTATION(2018)

Cited 0|Views2
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined